Radionuclide Therapies in Molecular Imaging and Precision Medicine

A Tuba Kendi; Valeria M Moncayo; Jonathon A Nye; James R Galt; Raghuveer Halkar; David M Schuster

doi:10.1016/j.cpet.2016.08.006

Radionuclide Therapies in Molecular Imaging and Precision Medicine

PET Clin. 2017 Jan;12(1):93-103. doi: 10.1016/j.cpet.2016.08.006. Epub 2016 Sep 19.

Authors

A Tuba Kendi¹, Valeria M Moncayo², Jonathon A Nye³, James R Galt³, Raghuveer Halkar², David M Schuster²

Affiliations

¹ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University School of Medicine, 1364 Clifton Road Northeast, Atlanta, GA 30322, USA. Electronic address: drtubakendi@yahoo.com.
² Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University School of Medicine, 1364 Clifton Road Northeast, Atlanta, GA 30322, USA.
³ Division of Research, Department of Radiology and Imaging Sciences, Emory University School of Medicine, 1364 Clifton Road Northeast, Atlanta, GA 30322, USA.

PMID: 27863570
DOI: 10.1016/j.cpet.2016.08.006

Abstract

This article reviews recent advances and applications of radionuclide therapy. Individualized precision medicine, new treatments, and the evolving role of radionuclide therapy are discussed.

Keywords: (131)I MIBG; (131)I therapy; (90)Y microspheres; PET/CT; Peptide radionuclide receptor therapy; SPECT/CT.

Publication types

Review

MeSH terms

3-Iodobenzylguanidine / therapeutic use
Humans
Iodine Radioisotopes / therapeutic use
Microspheres
Molecular Imaging*
Molecular Targeted Therapy*
Multimodal Imaging*
Neoplasms / diagnostic imaging*
Neoplasms / radiotherapy*
Precision Medicine*
Radioisotopes / therapeutic use
Radiopharmaceuticals / therapeutic use
Radiotherapy Dosage
Sodium Iodide / therapeutic use
Yttrium Radioisotopes / therapeutic use

Substances

Iodine Radioisotopes
Radioisotopes
Radiopharmaceuticals
Yttrium Radioisotopes
3-Iodobenzylguanidine
Sodium Iodide